Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Eat Disord ; 50(2): 127-138, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27566987

ABSTRACT

OBJECTIVE: Individuals with anorexia nervosa (AN) and body dysmorphic disorder (BDD) exhibit distorted perception and negative evaluations of their own appearance; however, little is known about how they perceive others' appearance, and whether or not the conditions share perceptual distortions. METHOD: Thirty participants with BDD, 22 with AN, now weight-restored, and 39 healthy comparison participants (HC) rated photographs of others' faces and bodies on attractiveness, how overweight or underweight they were, and how much photographs triggered thoughts of their own appearance. We compared responses among groups by stimulus type and by level-of-detail (spatial frequency). RESULTS: Compared to HCs, AN and BDD had lower attractiveness ratings for others' bodies and faces for high-detail and low-detail images, rated bodies as more overweight, and were more triggered to think of their own appearance for faces and bodies. In AN, symptom severity was associated with greater triggering of thoughts of own appearance and higher endorsement of overweight ratings for bodies. In BDD, symptom severity was associated with greater triggering of thoughts of own appearance for bodies and higher overweight ratings for low-detail images. BDD was more triggered to think of own facial appearance than AN. DISCUSSION: AN and BDD show similar behavioral phenotypes of negative appearance evaluations for others' faces and bodies, and have thoughts of their own appearance triggered even for images outside of their primary appearance concerns, suggesting a more complex cross-disorder body-image phenotype than previously assumed. Future treatment strategies may benefit from addressing how these individuals evaluate others in addition to themselves. © 2016 Wiley Periodicals, Inc.(Int J Eat Disord 2017; 50:127-138).


Subject(s)
Anorexia Nervosa/psychology , Body Dysmorphic Disorders/psychology , Body Image , Face , Adult , Anorexia Nervosa/complications , Body Dysmorphic Disorders/diagnosis , Female , Humans , Male , Overweight/psychology , Thinness/psychology , Young Adult
2.
Hum Brain Mapp ; 36(4): 1442-57, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25504918

ABSTRACT

BACKGROUND: Impairment in episodic memory is one of the most robust findings in schizophrenia. Disruptions of fronto-temporal functional connectivity that could explain some aspects of these deficits have been reported. Recent work has identified abnormal hippocampal function in unmedicated patients with schizophrenia (SZ), such as increased metabolism and glutamate content that are not always seen in medicated SZ. For these reasons, we hypothesized that altered fronto-temporal connectivity might originate from the hippocampus and might be partially restored by antipsychotic medication. METHODS: Granger causality methods were used to evaluate the effective connectivity between frontal and temporal regions in 21 unmedicated SZ and 20 matched healthy controls (HC) during performance of an episodic memory retrieval task. In 16 SZ, effective connectivity between these regions was evaluated before and after 1-week of antipsychotic treatment. RESULTS: In HC, significant effective connectivity originating from the right hippocampus to frontal regions was identified. Compared to HC, unmedicated SZ showed significant altered fronto-temporal effective connectivity, including reduced right hippocampal to right medial frontal connectivity. After 1-week of antipsychotic treatment, connectivity more closely resembled the patterns observed in HC, including increased effective connectivity from the right hippocampus to frontal regions. CONCLUSIONS: These results support the notion that memory disruption in schizophrenia might originate from hippocampal dysfunction and that medication restores some aspects of fronto-temporal dysconnectivity. Patterns of fronto-temporal connectivity could provide valuable biomarkers to identify new treatments for the symptoms of schizophrenia, including memory deficits.


Subject(s)
Antipsychotic Agents/therapeutic use , Brain/physiopathology , Memory, Episodic , Psychotic Disorders/physiopathology , Schizophrenia/physiopathology , Adult , Brain/drug effects , Brain Mapping/methods , Causality , Female , Humans , Magnetic Resonance Imaging/methods , Male , Neural Pathways/drug effects , Neural Pathways/physiopathology , Neuropsychological Tests , Psychiatric Status Rating Scales , Psychotic Disorders/drug therapy , Risperidone/therapeutic use , Schizophrenia/drug therapy , Schizophrenic Psychology , Signal Processing, Computer-Assisted , Treatment Outcome
3.
Psychiatry Res ; 221(1): 6-12, 2014 Jan 30.
Article in English | MEDLINE | ID: mdl-24210948

ABSTRACT

We investigated the relationship between basal ganglia volume and treatment response to the atypical antipsychotic medication risperidone in unmedicated patients with schizophrenia. Basal ganglia volumes included the bilateral caudate, putamen, and pallidum and were measured using the Freesurfer automated segmentation pipeline in 23 subjects. Also, baseline symptom severity, duration of illness, age, gender, time off medication, and exposure to previous antipsychotic were measured. Treatment response was significantly correlated with all three regions of the bilateral basal ganglia (caudate, putamen, and pallidum), baseline symptom severity, duration of illness, and age but not gender, time off antipsychotic medication, or exposure to previous antipsychotic medication. The caudate volume was the basal ganglia region that demonstrated the strongest correlation with treatment response and was significantly negatively correlated with patient age. Caudate volume was not significantly correlated with any other measure. We demonstrated a novel finding that the caudate volume explains a significant amount of the variance in treatment response over the course of 6 weeks of risperidone pharmacotherapy even when controlling for baseline symptom severity and duration of illness.


Subject(s)
Antipsychotic Agents/adverse effects , Basal Ganglia/anatomy & histology , Basal Ganglia/drug effects , Risperidone/adverse effects , Schizophrenia/drug therapy , Adolescent , Adult , Antipsychotic Agents/therapeutic use , Basal Ganglia/pathology , Basal Ganglia Diseases/chemically induced , Basal Ganglia Diseases/diagnosis , Basal Ganglia Diseases/pathology , Caudate Nucleus/anatomy & histology , Caudate Nucleus/drug effects , Caudate Nucleus/pathology , Female , Globus Pallidus/anatomy & histology , Globus Pallidus/drug effects , Globus Pallidus/pathology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Organ Size , Risperidone/therapeutic use , Schizophrenia/diagnosis , Severity of Illness Index , Time Factors
4.
Neuroimage ; 63(3): 1127-33, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-22885248

ABSTRACT

This study examines the neural mechanisms through which younger and older adults ignore irrelevant information, a process that is necessary to effectively encode new memories. Some age-related memory deficits have been linked to a diminished ability to dynamically gate sensory input, resulting in problems inhibiting the processing of distracting stimuli. Whereas oscillatory power in the alpha band (8-12 Hz) over visual cortical areas is thought to dynamically gate sensory input in younger adults, it is not known whether older adults use the same mechanism to gate out sensory input. Here we identified a task in which both older and younger adults could suppress the processing of irrelevant sensory stimuli, allowing us to use electroencephalography (EEG) to explore the neural activity associated with suppression of visual processing. As expected, we found that the younger adults' suppression of visual processing was correlated with robust modulation of alpha oscillatory power. However, older adults did not modulate alpha power to suppress processing of visual information. These results demonstrate that suppression of alpha power is not necessary to inhibit the processing of distracting stimuli in older adults, suggesting the existence of alternative strategies for suppressing irrelevant, potentially distracting information.


Subject(s)
Aging/physiology , Sensory Gating/physiology , Visual Perception/physiology , Adult , Aged , Attention/physiology , Electroencephalography , Female , Humans , Male , Memory, Short-Term/physiology , Middle Aged , Young Adult
5.
Schizophr Res ; 140(1-3): 136-42, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22831772

ABSTRACT

BACKGROUND: Studies have shown that individuals with schizophrenia suffer from memory impairments. In this study, we combined proton magnetic resonance spectroscopy (¹H-MRS) and functional magnetic resonance imaging (fMRI) to clarify the neurobiology of memory deficits in schizophrenia. METHODS: We used single-voxel MRS acquired in the left hippocampus and fMRI during performance of a memory task to obtain measures of neurochemistry and functional response in 28 stable, medicated participants with schizophrenia (SZ) and 28 matched healthy controls (HC). RESULTS: The SZ group had significantly decreased blood oxygen level-dependent (BOLD) signal in left inferior frontal gyrus (IFG) during encoding and in the anterior cingulate cortex (ACC) and superior temporal gyrus (STG) during retrieval. We did not find significant differences in N-acetylaspartate/creatine (NAA/Cr) or glutamate+glutamine (Glx/Cr) levels between the groups, but did find a significant positive correlation between NAA/Cr and Glx/Cr in the HC group that was absent in the SZ group. There were no significant correlations between BOLD and MRS measured in the hippocampus. Further analyses revealed a negative correlation between left IFG BOLD and task performance in the SZ group. Finally, in the HC group, the left IFG BOLD was positively correlated with Glx/Cr. CONCLUSIONS: We replicated findings of reduced BOLD signal in left IFG and of an altered relationship between IFG BOLD response and task performance in the SZ. The absence of correlation between NAA/Cr and Glx/Cr levels in patients might suggest underlying pathologies of the glutamate-glutamine cycle and/or mitochondria.


Subject(s)
Hippocampus/blood supply , Hippocampus/metabolism , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Schizophrenia/pathology , Adult , Analysis of Variance , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Creatine/metabolism , Female , Glutamic Acid/metabolism , Glutamine/metabolism , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Oxygen/blood , Protons , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...